Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2009 December;75(12) > Minerva Anestesiologica 2009 December;75(12):698-702

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

EXPERTS’ OPINION   Freefree

Minerva Anestesiologica 2009 December;75(12):698-702

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

What anesthesiologists should know about B-type natriuretic peptide

Noveanu M., Hartwiger S., Mueller C.

Department of Internal Medicine, University Hospital, Basel, Switzerland


PDF


Natriuretic peptides (NPs), particularly B-type natriuretic peptide (BNP) and N-terminal pro BNP (NT-proBNP), are widely used as markers of cardiac wall stress and heart failure (HF) in daily clinical practice. The measurement of NPs became a part of national and international cardiovascular guidelines for the diagnosis and treatment of HF. NP measurement improves diagnosis and management and helps to predict outcome in patients presenting with acute dyspnea in the Emergency Department. Additionally, NPs are of special interest for anesthesiologists. This includes improved management of Intensive Care Unit patients with respiratory failure and preoperative risk assessment. This paper reviews and highlights the use of NPs in clinical practice focusing on issues that may be of particular interest to anesthesiologists.

top of page